by azguy | Aug 27, 2025
Silver Spring, Maryland—The FDA has provided additional information to patients and medical providers regarding the recall of the Comprehensive Reverse Shoulder Implant initiated by Zimmer Biomet on December 20, 2016. The recall has been designated a “Class...
by azguy | Aug 27, 2025
Phoenix, Arizona—On December 20, 2016, Zimmer Biomet announced a recall of its Comprehensive Reverse Shoulder Implant based on a higher-than-expected fracture rate. More information on the Comprehensive Reverse Shoulder recall and the affected devices can be found...
by azguy | Aug 27, 2025
The FDA announced a Class 1 recall of the Zimmer Biomet Comprehensive Shoulder Implant Model 115340 based on information that the device is associated with a higher-than-expected failure rate. The following information will help patients and medical providers identify...
by azguy | Aug 27, 2025
The FDA issued an order restricting the sale and distribution of Essure implants, a response to reports that side effects attributed to the device pose a risk to women. The FDA action is intended to ensure that women considering the Essure device for birth control are...
by azguy | Aug 27, 2025
Bayer announced today that it will stop selling its Essure birth control device in the United States. The device has been plagued by reports of serious side effects, with thousands of women reporting problems to the FDA. The FDA has received more than 26,000 adverse...
